RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.71B
1-Year Est. Return
43.68%
1 Year Est. Return
+43.68%
AUM
$1.6B
AUM Growth
-$143M
(-8.2%)
Holding
105
Top Buys
| 1 | +$21.5M | |
| 2 | +$21.2M | |
| 3 | +$16.8M | |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$12.6M |
| 5 |
Arcellx
ACLX
|
+$12.3M |
Top Sells
| 1 | +$105M | |
| 2 | +$25.5M | |
| 3 | +$23.9M | |
| 4 |
Legend Biotech
LEGN
|
+$17.4M |
| 5 |
UnitedHealth
UNH
|
+$15.6M |
Sector Composition
| 1 | Healthcare | 98.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INZY
101
DELISTED
Inozyme Pharma
INZY
| – | – |
-3,445,299
|
|
||
|
102
Legend Biotech
LEGN
$4.36B
| – | – |
-512,932
|
|
||
103
MacroGenics
MGNX
$116M
| – | – |
-1,145,214
|
|
||
104
Pliant Therapeutics
PLRX
$81.1M
| – | – |
-589,996
|
|